NCEL CIK: 1783036

NewcelX Ltd.

  • Switzerland
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−14.9
FY22:
−13.9
FY23:
−3.44
FY24:
−1.07
FY25:
−2.77
Change from FY21 to FY25
millions USD
FY21:
−0.04
FY22:
–
FY23:
0.10
FY24:
−0.01
FY25:
1.70
Change from FY21 to FY25
millions USD
FY21:
20.3
FY22:
17.4
FY23:
2.85
FY24:
0.45
FY25:
2.63
millions USD
FY21:
5.34
FY22:
3.52
FY23:
−0.66
FY24:
−0.67
FY25:
1.55
(positive)
Change from FY21 to FY25
millions USD
FY21:
−15.0
FY22:
–
FY23:
−3.45
FY24:
−1.07
FY25:
−2.77

All amounts in millions USD Data source:SEC EDGAR